FRONTONASAL DYSPLASIA 3
|
0.600 |
GermlineCausalMutation
|
disease |
ORPHANET |
Disruption of ALX1 causes extreme microphthalmia and severe facial clefting: expanding the spectrum of autosomal-recessive ALX-related frontonasal dysplasia.
|
20451171 |
2010 |
FRONTONASAL DYSPLASIA 3
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Neoplasm Metastasis
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
In this study, we found that increased expression of ALX1 was associated with the progression of osteosarcoma and that ALX1 protein levels were significantly elevated in matched distant metastases.
|
25736924 |
2015 |
Neoplasm Metastasis
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
CART1 is specifically expressed by epithelial cells in breast carcinomas and metastases.
|
7592751 |
1995 |
Secondary Neoplasm
|
0.020 |
AlteredExpression
|
group |
BEFREE |
CART1 is specifically expressed by epithelial cells in breast carcinomas and metastases.
|
7592751 |
1995 |
Secondary Neoplasm
|
0.020 |
AlteredExpression
|
group |
BEFREE |
In this study, we found that increased expression of ALX1 was associated with the progression of osteosarcoma and that ALX1 protein levels were significantly elevated in matched distant metastases.
|
25736924 |
2015 |
Osteosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
High ALX1 levels also predict shorter overall survival of osteosarcoma patients.
|
25736924 |
2015 |
Osteosarcoma of bone
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
High ALX1 levels also predict shorter overall survival of osteosarcoma patients.
|
25736924 |
2015 |
Childhood Osteosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
High ALX1 levels also predict shorter overall survival of osteosarcoma patients.
|
25736924 |
2015 |
FRONTONASAL DYSPLASIA 3
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Aristaless-Like Homeobox protein 1 (ALX1) variant associated with craniofacial structure and frontonasal dysplasia in Burmese cats.
|
26610632 |
2016 |
FRONTONASAL DYSPLASIA 3
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Disruption of ALX1 causes extreme microphthalmia and severe facial clefting: expanding the spectrum of autosomal-recessive ALX-related frontonasal dysplasia.
|
20451171 |
2010 |
FRONTONASAL DYSPLASIA 3
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Defective neural crest migration revealed by a Zebrafish model of Alx1-related frontonasal dysplasia.
|
23059813 |
2013 |
FRONTONASAL DYSPLASIA 3
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Disruption of ALX1 causes extreme microphthalmia and severe facial clefting: expanding the spectrum of autosomal-recessive ALX-related frontonasal dysplasia.
|
20451171 |
2010 |
Frontonasal dysplasia
|
0.530 |
Biomarker
|
disease |
BEFREE |
Only a small number of genes have been associated with FND phenotypes until now, the first gene being EFNB1, related to craniofrontonasal syndrome (CFNS) with craniosynostosis in addition, and more recently the aristaless-like homeobox genes ALX3, ALX4, and ALX1, which have been related with distinct phenotypes named FND1, FND2, and FND3 respectively.
|
24376213 |
2014 |
Frontonasal dysplasia
|
0.530 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Our study concludes that the splice site variant identified in the ALX1 gene causes mild form of FND.
|
27324866 |
2017 |
Frontonasal dysplasia
|
0.530 |
Biomarker
|
disease |
CTD_human |
|
|
|
Craniofacial Abnormalities
|
0.300 |
Biomarker
|
group |
CTD_human |
Physical and genetic interactions between Alx4 and Cart1.
|
9847249 |
1999 |
Frontonasal dysplasia, severe microphthalmia, severe facial clefting syndrome
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Frontonasal dysplasia, severe microphthalmia, severe facial clefting syndrome
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Microphthalmos
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Microphthalmos
|
0.110 |
Biomarker
|
disease |
BEFREE |
Disruption of ALX1 causes extreme microphthalmia and severe facial clefting: expanding the spectrum of autosomal-recessive ALX-related frontonasal dysplasia.
|
20451171 |
2010 |
Blepharoptosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cleft Palate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Conductive hearing loss
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Orbital separation excessive
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|